Latest Headlines
September 27, 2024
CABINET Trial Supports Multitargeted Tyrosine Kinase Inhibitor for Advanced Neuroendocrine Tumors
The ASCO Post
September 27, 2024
Community-Academic Partnership May Successfully Reduce Radon-Related Lung Cancer Risk in Native Population
The ASCO Post
September 27, 2024
Olanzapine May Reduce Chemotherapy-Induced Nausea and Improve Quality of Life Among Patients With Cancer
The ASCO Post
September 27, 2024
Datopotamab Deruxtecan vs Docetaxel in Previously Treated Advanced or Metastatic NSCLC
The ASCO Post
Daily News
Stay up to date with the latest clinical headlines.
Thank you for signing up for the Daily News alerts. You will begin receiving them shortly.
September 26, 2024
Overall Survival Results With Pembrolizumab and Chemoradiotherapy in Newly Diagnosed, High-Risk, Locally Advanced Cervical Cancer
The ASCO Post
September 26, 2024
Quality-of-Life Outcomes: Whole-Breast Irradiation vs Accelerated Partial-Breast Irradiation Following Breast-Conserving Surgery
The ASCO Post
September 26, 2024
Breast Cancer Diagnosis: 55% Gain in Efficiency With AI-Assisted Pathology
Conexiant
September 26, 2024
Atezolizumab, Venetoclax, and Obinutuzumab in Richter Transformation Diffuse Large B-Cell Lymphoma
The ASCO Post
Advertisement
Recommendations
Advertisement